QI Path provides an AI-driven, adaptive risk intelligence platform that enables organizations in life sciences, healthcare, and government to proactively identify, mitigate, and govern operational risks to ensure quality and compliance.
QI Path is a software development company that provides an AI-driven, cloud-based risk intelligence platform designed for highly regulated industries, including life sciences, healthcare, and government agencies. The platform automates risk analysis and mitigation by integrating real-time AI insights, historical data, and frontline perspectives. By combining systems improvement methodologies, such as Lean Six Sigma principles, with intelligent automation, the software enables organizations to identify, prioritize, and address operational vulnerabilities—ranging from clinical trial deviations and manufacturing integrity issues to patient safety risks—before they escalate into costly failures or compliance gaps.
The platform is engineered to support regulatory readiness and operational excellence, helping teams reduce quality and safety issues, minimize waste, and accelerate data-informed decision-making. By transforming reactive "investigate and recover" workflows into proactive, adaptive risk management, QI Path serves a wide spectrum of users, from emerging biotech firms to federal defense partners. Its technology has been deployed to support complex environments, including clinical research operations and military medical readiness, with documented success in significantly reducing quality issues and improving overall organizational reliability.